Arbutus Biopharma Corporation ABUS Total debt

Total debt at other companies

Arrowhead ResearchARWR

$107.88M-5.6%

Gilead SciencesGILD

$26.25B+5.2%

ALN

Alnylam PharmaceuticalsALNY

$256.43M-5.2%

AnaptysBio, Inc.ANAB

$13.61K-99.9%

Avalo TherapeuticsAVTX

$242K-64.4%

Assembly BiosciencesASMB

$2.49M-17.5%

FAQ

What is Arbutus Biopharma Corporation's total debt?

Arbutus Biopharma Corporation (ABUS) reported total debt of $631K in Q1 2026.

How has Arbutus Biopharma Corporation's total debt changed year-over-year?

Arbutus Biopharma Corporation's total debt decreased by 46.9% year-over-year, from $1.19M to $631K.

What is the long-term trend for Arbutus Biopharma Corporation's total debt?

Over 5 years (2020 to 2025), Arbutus Biopharma Corporation's total debt has grown at a -24.2% compound annual growth rate (CAGR), from $2.98M to $746K.

What does total debt mean?

Total debt represents the aggregate sum of all interest-bearing financial obligations, including short-term borrowings, the current portion of long-term debt, and long-term debt instruments. It also encompasses capitalized lease liabilities and other debt-like financing arrangements that require fixed repayment schedules. This metric serves as a comprehensive indicator of a company's total financial leverage and its reliance on external capital providers.